Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders (2021)
Source: Neurology Neuroimmunology & Neuroinflammation. Unidades: FM, FMRP
Subjects: COVID-19, HOSPITALIZAÇÃO, FÁRMACOS IMUNOSSUPRESSORES, UNIDADES DE TERAPIA INTENSIVA, NEUROMIELITE ÓPTICA, ÍNDICE DE GRAVIDADE DA DOENÇA
ABNT
APÓSTOLOS-PEREIRA, Samira Luisa dos et al. Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders. Neurology Neuroimmunology & Neuroinflammation, v. 8, n. 6, p. 1-9, 2021Tradução . . Disponível em: https://doi.org/10.1212/NXI.0000000000001060. Acesso em: 01 nov. 2025.APA
Apóstolos-Pereira, S. L. dos, Ferreira, L. C., Boaventura, M., Sousa, N. A. de C., Martins, G. J., d'Almeida, J. A., et al. (2021). Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders. Neurology Neuroimmunology & Neuroinflammation, 8( 6), 1-9. doi:10.1212/NXI.0000000000001060NLM
Apóstolos-Pereira SL dos, Ferreira LC, Boaventura M, Sousa NA de C, Martins GJ, d'Almeida JA, Pitombeira M, Mendes LS, Fukuda T, Donadi EA. Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders [Internet]. Neurology Neuroimmunology & Neuroinflammation. 2021 ; 8( 6): 1-9.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1212/NXI.0000000000001060Vancouver
Apóstolos-Pereira SL dos, Ferreira LC, Boaventura M, Sousa NA de C, Martins GJ, d'Almeida JA, Pitombeira M, Mendes LS, Fukuda T, Donadi EA. Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders [Internet]. Neurology Neuroimmunology & Neuroinflammation. 2021 ; 8( 6): 1-9.[citado 2025 nov. 01 ] Available from: https://doi.org/10.1212/NXI.0000000000001060
